Intercept to Announce First Quarter 2022 Financial Results on May 6, 2022

Rhea-AI Summary

Intercept Pharmaceuticals (Nasdaq: ICPT) will report its first quarter 2022 financial results before market opening on May 6, 2022. The announcement will be followed by a conference call at 8:30 a.m. ET to discuss the results. Interested parties can access the conference call on the company's investor webpage or by calling a designated toll-free number. Intercept focuses on innovative treatments for progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH).

Positive

• Upcoming announcement of Q1 2022 financial results may provide insights into company performance.

Negative

• None.

MORRISTOWN, N.J., May 02, 2022 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, will announce its first quarter 2022 financial results prior to market open on Friday, May 6, 2022. The announcement will be followed by a conference call and audio webcast hosted by Intercept management at 8:30 a.m. ET to discuss the results.

The conference call will be available on the investor page of our website at http://ir.interceptpharma.com or by calling (855) 232-3919 (toll-free) with passcode 7738727. Archived webcasts will be available on Intercept’s website for approximately two weeks.

About Intercept:
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002, Intercept has operations in the United States, Europe, and Canada. For more information, please visit www.interceptpharma.com or connect with the company on Twitter and LinkedIn.

Contact:
For more information about Intercept, please contact:

Investor inquiries: investors@interceptpharma.com 

Media inquiries: media@interceptpharma.com

FAQ

When will Intercept Pharmaceuticals announce its first quarter 2022 financial results?

Intercept Pharmaceuticals will announce its first quarter 2022 financial results on May 6, 2022.

What time is the conference call for Intercept Pharmaceuticals' Q1 2022 results?

The conference call will take place at 8:30 a.m. ET on May 6, 2022.

How can I access the conference call for Intercept Pharmaceuticals' financial results?

The conference call can be accessed via their investor webpage or by calling a designated toll-free number.

What diseases does Intercept Pharmaceuticals focus on?

Intercept Pharmaceuticals focuses on progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH).